BioXcel Therapeutics, Inc. bankruptcy filing

BioXcel Therapeutics, Inc. (CIK 1720893, BTAI) reported a bankruptcy or receivership to the SEC on Form 8-K under Item 1.03, the latest filed 2026-08-28. It gives its business address as New Haven, Connecticut. Its registered industry is Pharmaceutical Preparations. The sentences below are quoted from the filings as written.

The filings

Form 8-K filed 2026-08-28 · Chapter 11

The petition

On August 27, 2026 (the "Petition Date"), BioXcel Therapeutics, Inc. (the "Company") and its subsidiaries OnkosXcel Therapeutics, LLC and OnkosXcel Employee Holdings, LLC (together with the Company, the "Debtors") each filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (such court, the "Court" and such cases, the "Cases").

Case

The Debtors have requested that the Cases be jointly administered under the caption "In re BioXcel Therapeutics, Inc., et al." The Debtors will continue to operate their businesses as "debtors-in-possession" under the jurisdiction of the Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Court.

Open the filing

Where this comes from

Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.

The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.

All recent bankruptcy filingsThat week